Enzymmanagement.Ag

enzymmanagement.ag is an R&D pharmaceutical company based in Tägerwilen, Switzerland, directly originated from the Institute for Clinical Research – founded in Hamburg, Germany, in 1978. Focus of enzymmanagement ag is the invention, development and production of bioactive topical treatments targeting benign tumors of fatty tissues (including rare diseases – e.g. Multiple Symmetric Lipomatosis) and Estradiol depending breast cancer. The company has access to an extended portfolio of internationally granted patents.